Results 291 to 300 of about 304,614 (388)

A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma

open access: yesInvestigational new drugs, 2005
R. Kefford   +12 more
semanticscholar   +1 more source

Pharmacological Characterization of YM598, a Selective Endothelin-A Receptor Antagonist

open access: bronze, 2004
Katsumi Sudoh   +8 more
openalex   +1 more source

The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failure

open access: bronze, 2004
Gad Cotter   +14 more
openalex   +1 more source

Home - About - Disclaimer - Privacy